Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Stuart J. Wong MD
Center Director, Professor
Department of Medicine
Division of Hematology and Oncology - Medicine

OFFICE ADDRESS:
Froedtert Hospital
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
09/1981 - 06/1985 AB - Mathematics, Occidental College, Los Angeles, CA
09/1983 - 06/1984 Junior Year Abroad Program, University of Sussex, Sussex, England
08/1986 - 05/1990 MD, Medical College of Wisconsin, Milwaukee, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/1990 - 06/1993 Resident, Internal Medicine
07/1994 - 06/1998 Hematology Oncology Fellow, Division of Hematology/Oncology
01/2000 - 12/2001 K30 Clinical Research Scholar Program

FACULTY APPOINTMENTS:
07/1993 - 06/1994 Clinical Instructor, Department of Medicine, Division of General Internal Medicine
07/1998 - 06/2007 Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
07/2007 - Present Associate Professor, Department of Medicine, Division of Neoplastic Diseases, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
07/1998 - 2002 Director, Hematology Oncology Core Curriculum, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
1993 - Present Hematology Oncology, Froedtert Memorial Lutheran Hospital, Milwaukee, WI
1993 - Present Zablocki Veterans Affairs Medical Center, 5000 W. National Ave., Milwaukee, WI 53295

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
ABIM- Internal Medicine
1993
12/31/2003
ABIM - Medical Oncology
1998
12/31/2018
American Board of Internal Medicine
None
 
Licensure
Number Issue DateExpiration
Wisconsin License
33593
1991
10/31/2011
 

AWARDS AND HONORS:
2008 - Present RTOG Next Generation Investigator Award , Radiation Therapy Oncology Group, 40th Anniversary Celebration

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1983 - 1984 National Mathematics Honor Society (Pi Mu Epsilon)
1991 - Present Wisconsin State Medical Society (Member )
1998 - Present Eastern Cooperative Oncology Group (Head and Neck Cancer Committee)
1999 - Present American Society of Clinical Oncology (Member )
1999 - Present Radiation Therapy Oncology Group (Gastrointestinal Cancer Committee)
1999 - Present Radiation Therapy Oncology Group (Medical Oncology Committee )
1999 - Present Radiation Therapy Oncology Group (Head and Neck Cancer Committee)
1999 - Present Radiation Therapy Oncology Group (Translational Research Program)
2001 - Present American Society for Therapeutic Radiation and Oncology (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
2001 - 2008 MCW Healthlink
2006 - 2010 Journal of Clinical Oncology
Journal Review
UpToDate
Journal of Palliative Medicine
Cancer Chemotherapy and Pharmacology
RTOG Publications Committee
Journal of Clinical Oncology
Annals of Oncology
International Journal of Radiation Oncology Biology Physics
Head & Neck

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
02/2003 - Present Lead Investigator, University of Chicago Phase II Consortium, National Cancer Institute

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
01/2004 - 2007 Chair, Head and Neck Cancer Subcommittee, RTOG Translational Research Program (TRP)
12/2004 - 2009 Member, RTOG Nominating Committee, Radiation Therapy Oncology Group (RTOG), National Cancer Institute, Cooperation Oncology Group
07/2005 - 06/2006 Chairperson-Elect, Scientific Program Committee, Head and Neck Cancer, American Society of Clinical Oncology
07/2005 - Present Member, Longitudinal Registry of Head and Neck Cancer (LORHAN) Advisory Committee, Radiation Therapy Oncology Group (RTOG), National Cancer Institute, Cooperation Oncology Group
07/2006 - Present Co-Chair, RTOG Head and Neck Cancer Committee, Radiation Therapy Oncology Group (RTOG), National Cancer Institute, Cooperation Oncology Group
07/2006 - Present Co-Chair, RTOG Medical Oncology Committee, Head and Neck Cancer
07/2006 - 06/2007 Chairperson, Scientific Program Committee, Head and Neck Cancer, American Society of Clinical Oncology
2007 - Present Member, Head and Neck Cancer Steering Committee, Metastatic/Recurrent Disease Task Force, National Institutes of Health, National Cancer Institute

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
National Cancer Institute, Northwestern University, Phase I & II Clinical Trials of Cancer Chemoprevention Agents
Source:
NIH, National Cancer Institute, Division of Chemoprevention, N01-CN-35157
Role:
Clinical investigator, Study Chair
Dates:
2006 - Present
 
Title:
RTOG, CA21661 32
Source:
NIH
Role:
Co-Chair of the Radiation Therapy Oncology Head and Neck & Medical Oncology Subcommittees
Dates:
01/2007 - Present
 
Title:
NWU 05-5-01, “A Phase I Trial of ALA PDT for Oral Leukoplakia”
Source:
NIH, National Cancer Institute, Division of Chemoprevention, N01-CN-35157
Role:
Site Principal Investigator
PI:
Self
Dates:
2007 - Present
 
Title:
NCI Protocol #8271 Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and Non-Adenoid Cystic Malignant Salivary Tumors
Source:
NCI
Role:
Study Chairperson, Principal Investigator
 
Title:
LOI #: 8271 “Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and Non-Adenoid Cystic Malignant Salivary Tumors”; University of Chicago Phase II Consortium “Early Therapeutics with Phase II Emphasis”
Source:
NIH, National Cancer Institute, N01 CM-17102-03
Role:
Study Chair
 
Title:
NCI Protocol #8271 Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and Non-Adenoid Cystic Malignant Salivary Tumors
Source:
NCI
Role:
Study Chairperson, Principal Investigator
PI:
Self
 
Non-Peer Review
Title:
Patterns of Chemotherapy Use in Patients Treated with Concurrent Radiation for Locally Advanced Head and Neck Cancer
Source:
Bristol Myer Squibb
Role:
Principal Investigator
PI:
Self
 
Pending
Peer Review
Title:
RTOG 0914 "A Randomized Phase I/II Study of Re-Irradiation with Cetuximab, and A12 Antibodies with or without Induction Chemotherapy in Resectable and Unresectable Recurrent or Second Primary Head and Neck Carcinoma Arising in a Previously Irradiated Field
Source:
NCI
Role:
Study Chairperson, Principal Investigator
 
Prior
Peer Review
Title:
Medical Student Summer Research Fellowship
Source:
Children’s Hospital of Los Angeles
Dates:
05/1987 - 08/1987
 
Title:
Radiosensitization in Locally Advanced Head and Neck Cancer: Relationship to Ribonucleotide Reductase Inhibition
Source:
NIH, 3M01RR00058-37S1 CAP Award
Role:
Awardee
Dates:
1999 - 2002
Direct Funds:
$301,500
 
Title:
Radiosensitization in Locally Advanced Head and Neck Cancer: Relationship to Ribonucleotide Reductase Inhibition
Source:
American Cancer Society – MCW Cancer Center
Role:
Principal Investigator
PI:
Self
Dates:
1999 - 2000
Direct Funds:
$17,500
 
Title:
RTOG 0214 “A Phase III Comparison Of Prophylactic Cranial Irradiation Versus Observation In Patients With Locally Advanced Non-Small Cell Lung Cancer”
Source:
Radiation Therapy Oncology Group National Cancer Institute
Role:
Study Co-Chairperson, Medical Oncology
Dates:
09/19/2002
 
Title:
Molecular Characterization of p53R2 in Head and Neck Cancer
Source:
NIH, R21 CA100581-01
Role:
Principal Investigator
PI:
Self
Dates:
07/2003 - 06/2005
Direct Funds:
$250,000
 
Title:
RTOG 0247 “A Phase II Randomized Trial of Preoperative Capecitabine and Irinotecan versus Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer”
Source:
Radiation Therapy Oncology Group
Role:
Study Co-Chairperson, Medical Oncology
PI:
RTOG
Dates:
03/15/2004
 
Title:
National Cancer Institute, University of Chicago Phase II Consortium “Early Therapeutics with Phase II Emphasis
Source:
NIH, National Cancer Institute, N01 CM-17102-03
Role:
Principal Investigator
PI:
Self
Dates:
01/2005 - 12/2009
 
Title:
RTOG 0421 “A Phase III Trial for Locally Recurrent Previously Irradiated Head and Neck Cancer: Concurrent Reirradiation and Chemotherapy versus Chemotherapy Alone”
Source:
Radiation Therapy Oncology Group, National Cancer Institute
Role:
Principal Investigator-Study Chairperson
PI:
Self
Dates:
04/27/2005 - Present
 
Title:
RTOG 0435 “A Randomized, Phase III, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Palifermin For The Reduction Of Oral Mucositis In Patients With Locally Advanced Head And Neck Cancer Receiving Radiation Therapy With Concurrent Chemotherapy”
Source:
Radiation Therapy Oncology Group, National Cancer Institute
Role:
Study Co-Chairperson, Medical Oncology
Dates:
07/06/2006
 
Title:
NWU 05-5-01, “A Phase I Trial of ALA PDT for Oral Leukoplakia”
Source:
NIH, National Cancer Institute, Division of Chemoprevention (DCP) Contract N01-CN-35157, Phase I & II Clinical Trials of Cancer Chemoprevention Agents Northwestern University Phase I/II Chemoprevention Consortium
Role:
Study Chairperson, Study Principal Investigator
PI:
Self
 
Title:
Radiosensitization in Locally advanced Head and Neck Cancer: Relationship to Ribonucleotide Reductase Inhibition
Role:
Principal Investigator
PI:
Self
 
Title:
RTOG 3501 A Phase II, Randomized, Double Blind, Placebo-Controlled Study Of Lapatinib With Chemoradiation For Non-Hpv Locally Advanced Head And Neck Cancer
Source:
RTOG Foundation
Role:
Study Chairperson, Principal Investigator
PI:
Self
 
Title:
RTOG 0619, “A Randomized Phase II Trial of Chemoradiotherapy versus Chemoradiotherapy and ZD6474 for High-Risk Postoperative Advanced Squamous Cell Carcinoma of The Head And Neck”
Source:
Radiation Therapy Oncology Group, National Cancer Institute
Role:
Study Co-Chairperson, Medical Oncology
 
Title:
Capecitabine for Advanced Squamous Cell Cancer of Head and Neck
Role:
Principal investigator
PI:
Self
 
Title:
A Phase II Trial of Pre-operative Capecitabine and Concurrent Radiation for Rectal Cancer
Role:
Principal Investigator
PI:
Self
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Ventricular Septal Rupture Following Myocardial Infarction, St. Joseph’s Hospital, Milwaukee, WI, 12/1991
The CBC, Nurse Practitioners Association of Milwaukee, Milwaukee, WI, 11/1994
New Developments in Locally Advanced Head and Neck Cancer, Oncology Pharmacists Meeting, Southeast Wisconsin, 04/2006
Use of Monoclonal Antibodies for Treatment of Solid Tumor Malignancies, Alumni Symposium for Senior Physicians, Medical College of Wisconsin, Milwaukee, WI, 10/2006
"Clinical Oncology Research at MCW---A Medical Oncology Perspective", MCW Division of Biostatistics, Statistical Seminar Series,, Milwaukee, WI, 04/2013 - Present
 
Regional
Re-Irradiation for Recurrent Head and Neck Cancer, Scientific Symposium, Southwestern Oncology Group Semi-Annual Meeting, Head and Neck Subcommittee, Kansas City, 10/2004
Site Visit, Eastern Cooperative Oncology Group, Site Audit, University of Minnesota, 11/2005
Re-Irradiation: Never Say Never Again, 2007 Annual American Society of Clinical Oncology Meeting, Chicago, IL, 06/2007
Integrating Intensity Modulated Radiation Therapy/Image-Guided Radiation Therapy and Systemic Chemotherapy Into a Combined Modality Therapeutic Strategy, 2008 Annual American Society of Clinical Oncology Meeting, Chicago, IL, 06/2008
Head and Neck Cancer, Poster Discussion, 2008 Annual American Society of Clinical Oncology Meeting, Chicago, IL, 06/2008
Discussant , Poster Discussion Session, Head and Neck Cancer, 2009 Annual American Society of Clinical Oncology Meeting, Chicago, IL, 06/2009
 
National
LY-1 B Cells in NZ B x W Mice, Children’s Hospital of Los Angeles, 08/1987
New Developments in Combined Modality Therapy in Non Small Cell Lung Cancer, Marquette, MD, 03/2000
New Developments in Non Small Cell Cancer Treatment, Medical Grand Rounds, Marquette General Hospital/Televised Marquette Health Care Network, 03/2000
New Developments in Medical Neoplasia, Alumni Day Lecture, Medical College of Wisconsin, 05/2003
ASCO 2004 Update: Head and Neck Cancer, RTOG Semi-Annual Meeting, Washington, DC, 06/2004
Radiation-Associated Oral Mucositis in Head and Neck Cancer, Radiation Oncology Department Grand Rounds, 10/2004
Radiation-Associated Oral Mucositis in Head and Neck Cancer, University of Chicago, Head and Neck Conference Grand Rounds, 11/2004
Abstracts 5500, 5501: Management of the Elderly Head and Neck Cancer Patient, 2006 Proceedings of American Society of Clinical Oncology (ASCO); Discussant, Head and Neck Oral Session, Atlanta, GA, 06/2006
Concurrent Chemotherapy and Radiation for Salivary Carcinomas, National Cancer Institute; Salivary Malignancy Workshop, Bethesda, MD, 11/2006
Concurrent Radiochemotherapy for Local Relapse or Second Primary, American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting, Philadelphia, PA; Presidential Course: Biology and Therapy of Head and Neck Carcinoma, 11/2006
Best of ASCO 2007: Head and Neck Cancer, 2007 Best of ASCO West Meeting, San Francisco, CA, 07/2007
RTOG 0247: A Randomized Phase II Study Of Neoadjuvant Capecitabine And Irinotecan Versus Capecitabine And Oxaliplatin With Concurrent Radiation Therapy For Locally Advanced Rectal, RTOG Semi-Annual Meeting, Philadelphia, PA, 06/2008
Local Regional Recurrent Disease, 2008 American Head and Neck Society Annual Meeting, San Francisco, CA, 07/2008
Systemic Chemotherapy for Nasopharyngeal Carcinoma, American Head and Neck Society Annual Meeting, San Francisco, CA, 07/2008
Use of Novel Therapies in RTOG Studies, American Head and Neck Society's 2010 Research Workshop on the Biology, Prevention & Treatment of Head & Neck Cancer, Arlington, VA, 10/2010
A Phase II Study of Dasatinib (BMS 354825) in Recurrent or Metastatic ckit-Expressing Adenoid Cystic (ACC) and Non-ACC Malignant Salivary Glands Tumors (MSGT) --- NCI 8271, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 06/2013 - Present
 
International
Ribonucleotide Reductase: A Target for Gemcitabine-Mediated Radiosensitization, Radiation Therapy Oncology Group (RTOG), Scientific Session, Lung Cancer Committee, Montreal, Canada, 06/2000
Capecitabine for Transplant Associated Skin Cancer, International Transplant Skin Cancer Collaborative (ITSCC), Annual Meeting, San Francisco, CA, 03/2003
Capecitabine for Non Melanoma Skin Cancer in Organ Transplant Recipients, Skin Cancer in Organ Transplant Patients Europe (SCOP), Annual meeting, University of Lyon, Lyon, France, 08/2004
New Developments in Locally Advanced Head and Neck Cancer, RTOG Semi-Annual Meeting, Research Associate Scientific Session, Toronto, Canada, 06/2006
Preoperative chemotherapy treatment in stage II - III: Monotherapy vs Combined therapy, XVI International Symposium advances in Treatment of Digestive Tumors, Malaga, Spain, 12/2009
 

COMMITTEE SERVICE:
Medical College of Wisconsin
07/1998 - Present Member, Pharmacy Nutrition and Therapy (PNT)Committee, Medical College of Wisconsin
07/1998 - 05/2005 Member, Residency Review Committee, Medical College of Wisconsin
07/2000 - Present Member, Neoplastic Diseases Fellowship Committee, Medical College of Wisconsin
01/2001 - 2003 Member, PNT Medication Error Committee, Medical College of Wisconsin
01/2002 - 2003 Co-chair, MCW Cancer Center Scientific Review Committee, Medical College of Wisconsin
2007 - 2008 Member, Epic Implementation Team, Neoplastic Diseases, Medical College of Wisconsin
2008 - 2011 Member, Nominating Committee, Faculty Council, Medical College of Wisconsin
2009 - Present Member, Advisory Committee, IRB, Medical College of Wisconsin
2009 - 2011 Member, IRB Committee #4, Medical College of Wisconsin
2010 - Present Chairman, PNT Cancer Subcommittee, Medical College of Wisconsin
2010 - Present Member, Innovations Task Force on Mentoring, Office of Research, Medical College of Wisconsin
2010 - Present Chairman, Skin Cancer Research Fund, Medical College of Wisconsin
2012 - Present Co-Chair, MCW Research Day Committee
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Community/Lay Public
10/2002 A New Oral Chemotherapy Drug for Rectal Cancer”, Channel 6 Morning Wake-Up News
 
Medical Student Education
01/2000 “Introduction to Medical Oncology” Medical College of Wisconsin, M2 Pathology Lecture
09/2003 “Introduction to Medical Oncology” Medical College of Wisconsin, M2 Pathology Lecture
“Lung Cancer” Junior Medical Students Core Curriculum
 
Resident and Fellow Education
02/1993 “Disseminated Intravascular Coagulation”, Med Path Conference
07/1995 “Ribonucleotide Reductase” Division of Hematology/Oncology Fellows Conference
10/1995 “Acute Myelogenous Leukemia” Internal Medicine Resident Conference
10/1995 “Carboplatin Dosing”, Division of Hematology/Oncology Fellows Conference
02/1996 “T-Cell Activation and Tyrosine Phosphorylation” Division of Hematology/Oncology Fellows Conference
07/1998 - 2002 Director, Hematology Oncology Core Curriculum
01/1999 “Clinical Pathology Conference” (CPC), Department of Medicine, Zablocki VA Medical Center
04/2002 “Are We There Yet: Organ Preservation for Head and Neck Cancer”, Otolaryngology
12/2002 “Hypercalcemia of Malignancy”, Internal Medicine Resident Noon Conference
01/2004 “Management of Head and Neck Cancer” Internal Medicine Resident Noon Conference
06/2004 “Management of Head and Neck Cancer: Medical Oncology Perspective” Otolaryngology
08/2005 “Chemotherapy for Head and Neck Cancer”, Radiation Oncology Resident Lecture Series
06/2006 “New Developments in Locally Advanced Head and Neck Cancer”, Otolaryngology
07/2006 - Present Tuesday Hematology Oncology Fellow Clinic
12/2007 “Head and Neck Cancer Update: Medical Oncology Perspective”, Radiation Oncology Resident Teaching Conference
04/2009 “Rectal and Anal Cancer Update: Medical Oncology Perspective”, Radiation Oncology Resident Teaching Conference
05/2009 “Diagnosis and Management of Malignant Melanoma” Internal Medicine Resident Academic Half Day Lecture
05/2010 “Diagnosis and Management of Malignant Melanoma” Internal Medicine Resident Academic Half Day Lecture
01/2011 “Novel Therapies in RTOG Studies”
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Wong, S.J. , Meropol, N.J, Winter, K., Anne, R., Kachnic, L, Rashid, A. Watson, J.C. Mitchell, E. Pollock, J. Lee, R.J., Haddock, M., Erickson, B., Willett, C. RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Locally Advanced Rectal Cancer. J. Clin. Oncol (Submitted, J Clin Oncol)
2. Leena, M. V., Michel, M.A., Firat, S., Loerhl T., Loehrl T., Wong, S. J. Paranasal Small Cell Carcinoma Associated with Methylenetetrahydrofolate Reductase Gene Mutation.
3. Davis, D.W., Seiwert, T.Y., Karrison T. G., Yan, D., Liu, W., McConkey, D.J., Pierce, C., Martin, L.E., Nichols, K., Wong, S.J. , Dancey, J.E. , Stenson, K, Blair, E., Dekker, A, Vokes, E.E., Cohen, E.E.W., Vascular Endothelial Growth Factor and Endothelial Cell Epidermal Growth Factor Receptor Activation Predicts Response to Bevacizumab and Erlotinib in Recurrent or Metastatic Head and Neck Cancer (Submitted, J Clin Oncol)
4. Wong S.J., Myette MS, Wereley JP, and Chitambar CR. Increased sensitivity of Hydroxyurea-resistant leukemic cells to gemcitabine. Clinical Cancer Research 5(2):439-43, 1999.
5. Green D.A., Antholine W.E., Wong S.J., Richardson, D.E., Chitambar, C.R. Inhibition of Malignant Cell Growth, by 311, a Novel Iron Chelator of the Pyridoxal, Isonicotinyl Hydrazone Class: Effect on the R2 subunit of Ribonucleotide Reductase, Clin Cancer Res. 2001 Nov;7(11):3574-9.
6. Hacein-Bey L, Baisden JL, Lemke DM, Wong SJ, Ulmer JL, Cusick JF. Treating osteoporotic and neoplastic vertebral compression fractures with vertebroplasty and kyphoplasty Palliat Med. 2005 Oct;8(5):931-8.
7. Ozcan C, Wong SJ, Hari P. Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab. N Engl J Med. 2006 Mar 2;354(9):980-2; discussion 980-2.
8. Wong, S. J. Machtay, M., Yi Li "Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Reirradiation and Chemotherapy or Chemotherapy Alone?", J Clin Oncol. 2006 Jun 10;24(17):2653-8.
9. A. Argiris, E. Cohen, T. Karrison, B. Esparaz, A. Mauer, R. Ansari, S. Wong, Y. Lu, M. Pins, J. Dancey, E. Vokes. A Phase II Trial Of Perifosine, An Oral AKT Inhibitor, In Recurrent Or Metastatic Head And Neck Cancer, Cancer Biol Ther. 2006 Jul 2;5(7)
10. Wang D, Schultz CJ, Jursinic PA, Bialkowski M, Zhu XR, Brown WD, Rand SD, Michel MA, Campbell BH, Wong S, Li XA, Wilson JF. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):143-51
11. Edmonson, D.A., Gruling, B.J., Urmanski, A.M., Wong, S.J., Levy, M.B., Oxaliplatin Hypersensitivity: Case Report and Successful Repeat Desensitization, Am J Ther. 2007 Jan-Feb;14(1):116-8.
12. Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S., Ang K. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol. 2007 Oct 20; 25 (30):4800-5.
13. Vernon, M.R., Maheshwari, M., Schultz, C.J., Michel, M.A., Wong, S.J., Campbell, B.H., Massey, B.L., Wilson, J.F., Wang, D. Clinical Outcomes Of Patients Receiving Integrated PET/CT guided Radiotherapy For Head And Neck Carcinoma, Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):678-84.
14. Wong, S.J., Spencer, S. Reirradiation and Concurrent Chemotherapy After Salvage Surgery: Pay Now or Pay Later, J. Clin Oncol. 2008 Dec. 1 26 (34):5500-5501
15. Cohen, E.E.W, Davis, D.W, Karrison T.G., Seiwert T.Y., Wong, S.J., Nattam, S., Kozloff, M.F., Clark, J.I., Yan, D., Liu, W, Pierce, C, Dancey, J.E., Stenson, K., Blair, E., Dekker, A., Vokes, E.E. Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study, The Lancet Oncology, Volume 10, Issue 3, 247 - 257, March 2009
16. Murphy BA, Chen A, Curran WJ Jr, Garden AS, Harari PM, Wong SJ, Ang KK. Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings. Support Care Cancer. 2009 Nov;17(11):1393-401. Epub 2009 Mar 5.
17. Wong, S.J., Harari, P.M., Garden, A.S., Schwartz, M., Bellm L., Chen, A., Curran, W.J., Murphy, B.A., and Ang, K.K. Longitudinal Oncology Registry Of Head And Neck Carcinoma: Analysis of Chemoradiation Treatment Approaches in the United States", Cancer. 2011 Apr 15;117(8):1679-86. doi: 10.1002/cncr.25721.
18. Sun, A., Bae, K, Gore, E. M., Movsas, B., Wong, S.J., Meyers, C.A, Bonner J. A, Schild S. E., Gaspar, L.E., Bogart, J.A., Werner-Wasik, M., and Choy, H. A phase III comparison of prophylactic cranial irradiation (PCI) versus observation in patients with locally advanced non-small cell lung cancer: Neurocognitive and quality of life analysis of Radiation Therapy Oncology Group 0214. J Clin Oncol. 2011 Jan 20;29(3):279-86.
19. Gore, E. M., Bae, K, Wong, S.J., Sun, A., Movsas, B., , Meyers, C.A, Bonner J. A, Schild S. E., Gaspar, L.E., Bogart, J.A., Werner-Wasik, M., and Choy, H. A phase III comparison of prophylactic cranial irradiation (PCI) versus observation in patients with locally advanced non-small cell lung cancer: Primary analysis of Radiation Therapy Oncology Group (RTOG) 0214. J Clin Oncol, J Clin Oncol. 2011 Jan 20;29(3):272-8.
20. Zundel MT, Michel MA, Schultz CJ, Maheshwari M, Wong SJ, Campbell BH, Massey BL, Blumin J, Wilson JF, Wang D. Comparison of Physical Examination and Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 4-6 Months After Radiotherapy to Assess Residual Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys. 2011 Feb 5.
21. Jordan Kharofa, Nicholas Choong, Dian Wang, Selim Firat, Christopher Schultz, Chitra Sadasiwan, Stuart Wong. Continuous Course Re-irradiation with Concurrent Carboplatin and Paclitaxel for Locally Recurrent, Non-metastatic Squamous Cell Carcinoma of the Head and Neck. Int.J.Radiat. Biol Phys. Provisionally accepted.
22. Kiran Devisetty, M.D., Stuart J. Wong, M.D., Loren K. Mell, M.D. How does TPF improve survival over PF? Lancet Oncology, In Press.
23. Wong, S.J. , Meropol, N.J, Winter, K., Anne, R., Kachnic, L, Rashid, A. Watson, J.C. Mitchell, E. Pollock, J. Lee, R.J., Haddock, M., Erickson, B., Willett, C. RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Locally Advanced Rectal Cancer. Int.J.Radiat. Biol Phys. In Press.
 
Books, Chapters, and Reviews
1. Gore EM, Wong, S.J.: Stage IIE Non Hodgkin's Lymphoma of the Oropharynx (book chapter) Winchester D(ed): Tumor Board Case Management, New York, NY Lippincott, 1997.
2. Jhala N, Siegal G.P., Wong S.J., Hackbarth D., Shidham V.B. Telangiectatic Osteosarcoma, In Orthopedic Surgery. Ed. Chansky HA, Talavera F, Anderson G, Keenan MAE.. eMedicine Journal, August 22 2001, Volume 2, Number 8. Book chapter.
3. Rao N, Wong S, Hackbarth DA, Panikkar V, Shidham VB: Postradiation Sarcoma, In Orthopedic Surgery. Ed. Chansky HA, Talavera F, Anderson G, Keenan MAE.. eMedicine Journal, August 22 2001, Volume 2, Number 8. Book chapter.
 
Non-Refereed Journal Publications/Original Papers
1. Wong, S.J., Schultz C.J. Re-Irradiation: Never Say Never Again, American Society of Clinical Oncology Educational Book, 43rd Annual Meeting, Spring 2007, p 339
2. Chung C.H., , Wong S. J., , Ang K.K., Hammond E.H., Dicker A.P.,Harari P.M., Le, Q.T. Strategic plans to promote head and neck cancer translational research within Radiation Therapy Oncology Group: A report from the Translational Research Program. International Journal of Radiation Oncology Biology Physics. 2007, .69 (2),S67-S78.
3. Wong S. J. American Society of Clinical Oncology 2007 Annual Meeting Summaries, Oral Abstract Presentations and Plenary Session from the 43rd Annual Meeting, Head and Neck Cancer. 2007, p109-114.
 
Abstracts
1. Wong S. J., Wereley J, Chitambar CR: Ribonucleotide reductase expression and iron transport in mitogen activate human T-lymphocytes: relationship to iron transport, transferrin receptor, ferritin, and DNA synthesis. Blood: 124b, 1996.
2. Wong S.J., Myette MS, Wereley JP, Chitambar CR: Supersensitivity to gemcitabine in hydroxyurea-resistant human leukemic CCRF-CEM cells. Presented at the 89th annual meeting of the American Association for Cancer Research New Orleans, LA. March 1999.
3. Chang C.C., Revolinski JP, Purpi D., Chitambar CR, Wong S.J. Measurement of Ribonucleotide Reductase R2 Subunit Expression by One-Step Multiplex Real-Time Quantitative RT-PCR. Proceedings of the American Association from Cancer Research 93rd Annual Meeting.
4. Wong S.J., Chang C.C., Revolinski JP, Chitambar C.R. Radiosensitizing Effects of Gallium Are Modulated by Expression of R2 Subunit of Ribonucleotide Reductase. Proceedings of the American Association from Cancer Research 93rd Annual Meeting.
5. Hacein-Bey, L, Baisden, J., Wong, S.J., Lemke, D, Henry, M, Ulmer J.L., Cusick, J.F., Treating Osteoporotic and Neoplastic Vertebral Compression Fractures with Vertebroplasty and Kyphoplasty.
6. S. J. Wong, C. Sadasiwan, B. Erickson, D. Ota, D. Mulkerin, J. Thomas, K. Holen, S. Meadows, P. Ritch, G. Telford, P. Redlich, E. Gore. "A Phase II Trial Of Pre-Operative Capecitabine And Concurrent Radiation For Locally Advanced Rectal Cancer", Abstract, 2004 Gastrointestinal Cancers Symposium, San Francisco, Jan, 2004
7. M. Mauer, E. E. W. Cohen, S. J. Wong, M. Kozloff, J. Winegarden, D. M. Gustin, E. E. Vokes. Phase I study of epidermal growth factor receptor (EGFR) inhibitor, erlotinib, and vascular endothelial growth factor monoclonal antibody, bevacizumab, in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). 2004 Proceedings of American Society of Clinical Oncology.
8. CJ. Langer, J. Harris, E. Horwitz, N. Nicolaou, M. Kies, W. Curran, S. Wong, K. K. Ang. Phase II trial of concurrent split course hyperfractionated radiotherapy (Hfx RT), cisplatin (DDP) and paclitaxel (P) in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck (SCCHN): Results of RTOG 9911. 2004 Proceeding of American Society of Clinical Oncology Abstract #5509
9. S. J. Wong, C. Sadasiwan, B. Erickson, D. Ota, D. Mulkerin, J. Thomas, K. Holen, S. Meadows, G. Telford, E. Gore. "A phase II trial of pre-operative capecitabine and concurrent radiation for locally advanced rectal cancer. 2004 Proceedings of American Society of Clinical Oncology.
10. Sadasiwan, C, Schultz, C, Firat, S, Campbell, B, Wong, S. Continuous Course Reirradiation With Concurrent Weekly Chemotherapy For Patients With Unresectable Recurrent Head And Neck Cancer. 2004 Malignancies of the Chest & Head and Neck, Lung Cancer 2004; 46: S80.
11. A. Argiris, E.E.W. Cohen, J.Wade, A. Mauer, D.Gustin, R. Ansari, S. Wong, T. Karrison, E.E. Vokes. A Phase II Trial of Perifosine in Patients with Recurrent or Metastatic Head and Neck Cancer. 2004 Malignancies of the Chest & Head and Neck, Lung Cancer 2004; 46: S66.
12. E. E. Vokes, E. E. Cohen, A. M. Mauer, T. G. Karrison, S. J. Wong, L. J. Skoog-Sluman, M. F. Kozloff, J. Dancey, A. Dekker, A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC) 2005 Proceeding of American Society of Clinical Oncology Abstract #5504
13. E. M. Horwitz, J. Harris, C. J. Langer, N. Nicolaou, M. Kies, W. Curran, S. J. Wong, K. Ang. Concurrent Split Course Hyperfractionated Radiotherapy (Hfx RT), Cisplatin (DDP) and Paclitaxel (P) in Patients with Recurrent, Previously Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN): Update of RTOG 9911. 2005 Proceeding of American Society of Clinical Oncology Abstract #5577
14. S. M. Smith, B. Pro, K. van Besien, K. Conner, T. Karrison, S. Wong, P. Stiff, E. Vokes. A Phase II Study of Epothilone B analog BMS-247550 (NSC 710428) in Patients with Relapsed Aggressive non-Hodgkin's lymphomas. 2005 Proceedings of American Society of Clinical Oncology Abstract #6625
15. S. J. Wong, Z. Agha, S. Milligan. Concurrent chemotherapy practice patterns for head and neck cancer: what is standard of care? 2005 Proceedings of American Society of Clinical Oncology, Abstract
16. Curran W., Chen A, Harari, P, Murphy B, Wong, S., Bellm, L , Gamber, D., Dawson D. , and Ang, K.. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN), a new national cancer registry, 2006 Proceedings of American Society of Clinical Oncology Abstract
17. Abidoye, O., Cohen, E.E.W., Wong, S., Kozloff, M., Stenson, K., Blair, E, Day, S. , Dancey, J., Vokes, E.E.. A Phase II Study of GW572016 in Recurrent/Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN), 2006 Proceedings of American Society of Clinical Oncology, Vol 24, No. 18S (June 20 Supplement), 2006
18. S. J. Wong, Z. Agha, S. Milligan. Concurrent chemotherapy practice patterns for head and neck cancer: What is standard of care? Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 5542
19. Chen,A., Curran, W. , Harari, P., Murphy, B., Wong, S, Bellm, L. , Gamber, D, Dawson, D., and Ang, K. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN), a new national cancer registry, 2006 American Head and Neck Society Meeting
20. Wong, S, Machtay, M. , Langer, C, Schultz, C., Ridge J.A., List, M, Konski, A, Pajak, T.F., Ang, K. RTOG 0421, A Phase III Trial For Recurrent, Previously Irradiated Head and Neck Cancer: Re-RT and CT vs CT Alone, 2006 American Head and Neck Society Meeting
21. T. Y. Seiwert, D. W. Davis, D. Yan, A. M. Mauer, T. Karrison, M. Kozloff, A. Dekker, S. J. Wong, E. E. Vokes, E. E. Cohen pKDR/KDR ratio predicts response in a phase I/II pharmacodynamic study of erlotinib and bevacizumab for recurrent or metastatic head and neck cancer (HNC). 2007 Proceedings of American Society of Clinical Oncology.
22. Wong, S.J., Winter, K., Meropol, N.J., Anne, R., Kachnic, L.A., Rashid, A., Watson, J.C., Mitchell, E.P., Pollock, J., R. J., Lee, Willett, C. G. RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal, 2008 Proceedings of American Society of Clinical Oncology, J Clin Oncol 26: 2008 (May 20 suppl; abstr 4021)
23. Cohen, E.E., Needles, B.M., Cullen, K.J., Wong, S.J., Wade, J.L., Ivy, S.P., , Villaflor, V.M., Seiwert, T.Y., Nichols, K., Vokes, E.E., Phase 2 study of sunitinib in refractory thyroid cancer, 2008 Proceedings of American Society of Clinical Oncology , J Clin Oncol 26: 2008 (May 20 suppl; abstr 6025)
24. Curran, W.J. , Chen, A. , Garden, A. , Harari, P. , Murphy, B. A., Wong, S. J., Bellm, L., Schwartz, M., Dawson, D. , Ang, K., Longitudinal oncology registry of head and neck carcinoma (LORHAN): Initial treatment findings. 2008 Proceedings of American Society of Clinical Oncology, J Clin Oncol 26: 2008 (May 20 suppl; abstr 6054)
25. E. Gore, K. Bae, S. Wong, J. Bonner, A. Sun, S. Schild, L. Gaspar, J.Bogart, M. Werner-Wasik, H. Choy. Initial analysis of RTOG 0214: A phase III comparison of prophylactic cranial irradiation (PCI) versus observation in patients with locally advanced non-small cell lung cancer (LA-NSCLC). Submitted to 2009 Proceedings of American Society of Clinical Oncology
26. K. K. Ang, W. J. Curran, A. Chen, A. S. Garden, P. Harari, B.A. Murphy, S. Wong, L. Bellm, M. Schwartz, D. Dawson Longitudinal oncology registry of head and neck carcinoma (LORHAN): first report of outcomes. Submitted to 2009 Proceedings of American Society of Clinical Oncology.
27. Daniel E. Cannon, Sunitha Sukumaran, Stuart Wong, Nicholas Choong, Becky L. Massey. Effect of Pre-treatment BMI on Feeding Tube Use and Dependence in Head and Neck Cancer Patients Undergoing Chemoradiation, Combined Otolaryngology Spring Meetings, April 2010 (abstract)
28. Wong, S., J., Campbell, B., Massey, B., Lynch, D., Cohen, E.E.W., Jovanovic, B.D., Bergan, R.C. A Phase I Trial of ALA PDT For Treatment of Oral Leukoplakia, 2009 NCI Translational meeting, November 2009.
29. Brinkerhoff, B., Campbell, B., Tripp, P., Wong, S., Choong, N. Treatment Delay in Advanced-stage Head and Neck Cancer Patients Treated with Concurrent Chemoradiotherapy, Multidisciplinary Head & Neck Cancer Symposium , Feb, 2010.
30. Wong, S., J., Campbell, B., Massey, B., Lynch, D., Cohen, E.E.W., Jovanovic, B.D., Bergan, R.C. A Phase I Trial of ALA PDT For Treatment of Oral Leukoplakia, Multidisciplinary Head & Neck Cancer Symposium , Feb, 2010.
31. Chen, A., Curran, W.J., Garden, A. S., Harari, P.M., Murphy, B.A., Wong,S.J., Bellm, L., Schwartz, M., and Ang, K.K. Longitudinal oncology registry of head and neck carcinoma (LORHAN): socioeconomic and supportive care findings, 2010 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting
32. Harari, P.M., Chen, A., Curran, W.J., Garden, A. S., Murphy, B.A., Wong,S.J., Bellm, L., Schwartz, M., and Ang, K.K. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN®): Overview of Data Set, 2010 Proceedings of American Society of Clinical Oncology.
33. Wong,S.J., Chen, A., Curran, W.J., Garden, A. S., Harari, P.M., Murphy, B.A., , Bellm, L., Schwartz, M., and Ang, K.K. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): Findings Related to the Oropharynx. 2010 Proceedings of American Society of Clinical Oncology.
34. B.A. Murphy, A. Chen, W. J. Curran, A. S. Garden, P. Harari, S. Wong, L. Bellm, M. Schwartz, J. Newman, D. Adkins, N. Hayes, U. Parvathaneni, D. Brachman, B. Ghabach, M. Guarino, M. Greenberg, A. Abitbol, P.R. Anné, and K. K. Ang. Longitudinal oncology registry of head and neck carcinoma (LORHAN): analysis of disparities in care. Annual Meeting, ASTRO 2011
35. M. DeMara, N. Duncan, S. Wong, M. Neuburg, Z. Lazarova and E B Olasz Expression of epidermal growth factor receptor (EGFR) and detection of mutant EGFR (EGFRvIII) in human cutaneous squamous cell carcinoma. Society for Investigative Dermatology, 2011.
36. Wong, S.J., Winter, K., Meropol, N.J., Anne, R., Kachnic, L.A., Rashid, A., Watson, J.C., Mitchell, E.P., Pollock, J., R. J., Lee, Willett, C. G. Update of results of RTOG 0247: a randomized phase II study of neoadjuvant capecitabine (C) and irinotecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer, 2011 Proceedings of American Society of Clinical Oncology, J Clin Oncol 29: 2011 (May 20 suppl; abstr 3517)
37. B. A. Murphy, A. Y. Chen, W. J. Curran Jr., A. S. Garden, P. M. Harari, S. J. Wong, L. A. Bellm, M. Schwartz, J. Newman, D. Adkins, D. N. Hayes, U. Parvathaneni, D. Brachman, B. Ghabach, C. Schneider, M. Greenberg, A. Abitbol, P. R. Anne, K. Ang. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): Analysis of disparities in care. 2011 Proceedings of American Society of Clinical Oncology, J Clin Oncol 29: 2011 (May 20 suppl; abstr 5533)
38. 38. Wong S, Malinoski FJ, Botteman M, Corral M, Covello KL, Lange J, Cuyún Carter G, Pennella E, Muehlenbein CE. Head and Neck Cancer US Treatment Patterns and Outcomes in Recurrent and Metastatic Patients, Multidisciplinary Head and Neck Symposium, 2012, Abstr#170.
39. 39. Johnson A, Tarima S, Wong S, Friedland DR, Runge CL. Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy. Eighth International Conference on Head and Neck Cancer, July 2012 (Oral abstract)
40. 40. Stuart J. Wong, Theodore Karrison, David N. Hayes, Merril Kies, Martin Edelman, Tawee Tanvetyanon, Athanassios Argiris, Dean Lim, Nabil F Saba, Albiruni R.A. Razak, Francis P. Worden, Heinz-Josef Lenz, Jill Gilbert, John D. Roberts, Everett Vokes, Ezra E.W. Cohen, A Phase II Study of Dasatinib (BMS 354825) in Recurrent or Metastatic ckit-Expressing Adenoid Cystic (ACC) and Non-ACC Malignant Salivary Glands Tumors (MSGT)— NCI 8271. J Clin Oncol 31, 2013 (suppl; abstr 6022)